Evidence map›Paper›PMID 38699424›Full record

ArticleFrontiers in public health2024

Do asymptomatic STEC-long-term carriers need to be isolated or decolonized? New evidence from a community case study and concepts in favor of an individualized strategy.

Friedhelm Sayk, Susanne Hauswaldt, Johannes K Knobloch, Jan Rupp, Martin Nitschke

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Concurrent outbreaks ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  6. Intestinal Carriage of Two DistinctPathogens (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Friedhelm SaykDepartment of Medicine I, Division of Gastroenterology and Nephrology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Susanne HauswaldtDepartment of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Johannes K KnoblochDepartment of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Jan RuppDepartment of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany.
Martin NitschkeDepartment of Medicine I, Division of Gastroenterology and Nephrology, University Hospital Schleswig-Holstein, Lübeck, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asymptomatic long-term carriers of Shigatoxin producing

Indexed as

Anti-Bacterial AgentsAzithromycinEscherichia coli InfectionsShiga-Toxigenic Escherichia coliCarrier StateHemolytic-Uremic SyndromeHumansAnti-Bacterial AgentsAzithromycinEHECfecal sheddingHUSlong-term carriageShigatoxinsocial restrictionssocio-economic burdenSTEC

Identifiers

PMID38699424
PMCPMC11064650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.